Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,17,975 Cr
Revenue (TTM)
₹7,028 Cr
Net Profit (TTM)
₹1,076 Cr
ROE
13.5 %
ROCE
16.3 %
P/E Ratio
109.7
P/B Ratio
12.6
Industry P/E
50.06
EV/EBITDA
59.8
Div. Yield
0.1 %
Debt to Equity
0.2
Book Value
₹96.5
EPS
₹11.7
Face value
10
Shares outstanding
972,146,843
CFO
₹3,430.35 Cr
EBITDA
₹4,696.72 Cr
Net Profit
₹2,574.63 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Max Healthcare
| 7.6 | 2.2 | 11.6 | 34.9 | 50.1 | -- | -- |
|
BSE Sensex
| 5.3 | 0.4 | 9.2 | 6.6 | 17.1 | 18.9 | 11.7 |
|
BSE Healthcare
| -4.6 | 0.9 | 5.1 | 17.0 | 27.1 | 21.6 | 10.3 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Max Healthcare
| 63.9 | 56.1 | -0.8 | 210.8 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Max Healthcare
|
1,213.8 | 1,17,974.9 | 7,028.5 | 1,075.9 | 21.2 | 12.5 | 109.7 | 12.6 |
| 7,063.5 | 1,01,523.5 | 21,794.0 | 1,472.1 | 10.4 | 18.4 | 70.2 | 12.4 | |
| 558.8 | 28,854.2 | 4,138.5 | 5,426.8 | 12.5 | 9.9 | 5.4 | 6.7 | |
| 755.3 | 56,988.0 | 7,782.8 | 797.9 | 15.4 | 10 | 73.6 | 6.4 | |
| 535.3 | 7,456.6 | 2,222.9 | 48.1 | 7.9 | 5 | 167.9 | 8.1 | |
| 1,458.8 | 9,627.7 | 1,261.6 | 193.5 | 18.7 | 15.3 | 50.1 | 7.1 | |
| 5,639.9 | 6,171.3 | 1,371.1 | 208.9 | 21.0 | 20.3 | 29.5 | 5.7 | |
| 1,903.4 | 38,913.4 | 5,583.1 | 790.6 | 17.9 | 23.3 | 49.2 | 10.7 | |
| 1,452.2 | 14,742.8 | 1,515.9 | 244.2 | 23.2 | 18 | 60.6 | 10.1 | |
| 514.1 | 4,948.8 | 880.5 | 130.6 | 18.5 | 10.3 | 37.9 | 3.1 |
No Review & Analysis are available.
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including bariatric surgery/metabolic, bone marrow transplant, cancer/oncology, cardiac science, endocrinology and... diabetes, eye care, gastroenterology, hepatology and endoscopy, kidney transplant, laparoscopic, liver transplant, neuro science, orthopedics, robotic surgery, urology, and vascular surgery. The company provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres in Delhi and National Capital Region, Maharashtra, Punjab, Uttar Pradesh, and Uttarakhand. The company was incorporated in 2001 and is based in Gurugram, India. Read more
Incorporated
2001
Chairman
Abhay Soi
Managing Director
Abhay Soi
Group
Max
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Max Healthcare Institute Ltd stood at ₹ 15,214 Cr as on 31-Mar-25
The share price of Max Healthcare Institute Ltd is ₹1,213.80 (NSE) and ₹1,213.55 (BSE) as of 20-Jun-2025 IST. Max Healthcare Institute Ltd has given a return of 50.14% in the last 3 years.
Max Healthcare Institute Ltd has a market capitalisation of ₹ 1,17,975 Cr as on 20-Jun-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Max Healthcare Institute Ltd is 12.58 times as on 20-Jun-2025, a 77% premium to its peers’ median range of 7.10 times.
The P/E ratio of Max Healthcare Institute Ltd is 109.65 times as on 20-Jun-2025, a 119% premium to its peers’ median range of 50.06 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Max Healthcare Institute Ltd and enter the required number of quantities and click on buy to purchase the shares of Max Healthcare Institute Ltd.
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including bariatric surgery/metabolic, bone marrow transplant, cancer/oncology, cardiac science, endocrinology and diabetes, eye care, gastroenterology, hepatology and endoscopy, kidney transplant, laparoscopic, liver transplant, neuro science, orthopedics, robotic surgery, urology, and vascular surgery. The company provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres in Delhi and National Capital Region, Maharashtra, Punjab, Uttar Pradesh, and Uttarakhand. The company was incorporated in 2001 and is based in Gurugram, India.
The promoter of Max Healthcare Institute Ltd is Abhay Soi. Abhay Soi owns 23.73 per cent of the total equity. The chairman of the company is Abhay Soi , and the managing director is Abhay Soi..
There is no promoter pledging in Max Healthcare Institute Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
1,01,523
|
|
|
56,988
|
|
|
38,913
|
|
|
28,854
|
|
|
14,743
|
|
|
9,628
|
|
|
7,457
|
|
|
6,171
|
|
|
4,949
|
| Max Healthcare Institute Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
12.46
|
|
Operating margin(%)
|
21.19
|
|
Net Margin(%)
|
14.98
|
|
Dividend yield(%)
|
0.12
|
Yes, TTM profit after tax of Max Healthcare Institute Ltd was ₹1,076 Cr.
₹50.80
(
